TNS2 and sarcoma: Comparative analysis of 148 GISTs versus other sarcomas and gastrointestinal primary tumors revealed markedly elevated TNS2 expression in GISTs, with 71.4% showing intermediate/strong staining compared to only 2.9% in other sarcomas [156].